var data={"title":"Acetaminophen (paracetamol): Pediatric drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Acetaminophen (paracetamol): Pediatric drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/5549?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">see &quot;Acetaminophen (paracetamol): Drug information&quot;</a> and <a href=\"topic.htm?path=acetaminophen-paracetamol-patient-drug-information\" class=\"drug drug_patient\">see &quot;Acetaminophen (paracetamol): Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F22782418\" class=\"block black-box-warn drugH1Div\"><span class=\"drugH1\">ALERT: US Boxed Warning</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Risk of medication errors and hepatotoxicity (injection):</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:2em;\">Take care when prescribing, preparing, and administering acetaminophen injection to avoid dosing errors that could result in accidental overdose and death. In particular, be careful to ensure the following: the dose in milligrams and milliliters is not confused; the dosing is based on weight for patients less than 50 kg; infusion pumps are properly programmed; and the total daily dose of acetaminophen from all sources does not exceed maximum daily limits.</p>\n        <p style=\"text-indent:-2em;margin-left:2em;\">Acetaminophen has been associated with cases of acute liver failure, at times resulting in liver transplant and death. Most of the cases of liver injury are associated with the use of acetaminophen at doses that exceed the maximum daily limits, and often involve more than 1 acetaminophen-containing product.</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129318\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Acephen [OTC];</li>\n      <li>Aspirin Free Anacin Extra Strength [OTC];</li>\n      <li>Cetafen Extra [OTC];</li>\n      <li>Cetafen [OTC];</li>\n      <li>FeverAll Adult [OTC];</li>\n      <li>FeverAll Children's [OTC];</li>\n      <li>FeverAll Infants' [OTC];</li>\n      <li>FeverAll Junior Strength [OTC];</li>\n      <li>Little Fevers [OTC];</li>\n      <li>Mapap Arthritis Pain [OTC];</li>\n      <li>Mapap Children's [OTC];</li>\n      <li>Mapap Extra Strength [OTC];</li>\n      <li>Mapap Infants' [OTC] [DSC];</li>\n      <li>Mapap [OTC];</li>\n      <li>Midol Long Lasting Relief [OTC];</li>\n      <li>Non-Aspirin Pain Reliever [OTC];</li>\n      <li>Nortemp Children's [OTC];</li>\n      <li>Ofirmev;</li>\n      <li>Pain &amp; Fever Children's [OTC];</li>\n      <li>Pain Eze [OTC];</li>\n      <li>Pharbetol Extra Strength [OTC];</li>\n      <li>Pharbetol [OTC];</li>\n      <li>Q-Pap Children's [OTC] [DSC];</li>\n      <li>Q-Pap Extra Strength [OTC] [DSC];</li>\n      <li>Q-Pap Infants' [OTC] [DSC];</li>\n      <li>Q-Pap [OTC] [DSC];</li>\n      <li>Silapap Children's [OTC];</li>\n      <li>Silapap Infants' [OTC] [DSC];</li>\n      <li>Triaminic Children's Fever Reducer Pain Reliever [OTC];</li>\n      <li>Tylenol 8 HR Arthritis Pain [OTC];</li>\n      <li>Tylenol 8 HR [OTC] [DSC];</li>\n      <li>Tylenol Children's [OTC];</li>\n      <li>Tylenol Extra Strength [OTC];</li>\n      <li>Tylenol Infants' [OTC];</li>\n      <li>Tylenol Jr. Meltaways [OTC] [DSC];</li>\n      <li>Tylenol [OTC];</li>\n      <li>Valorin Extra [OTC];</li>\n      <li>Valorin [OTC]</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129319\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Abenol;</li>\n      <li>Apo-Acetaminophen;</li>\n      <li>Atasol;</li>\n      <li>Novo-Gesic;</li>\n      <li>Pediatrix;</li>\n      <li>Tempra;</li>\n      <li>Tylenol</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1050747\" class=\"list_set htclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Therapeutic Category</span>\n    <ul>\n      <li>\n        <span class=\"list-set-name\">Analgesic, Nonopioid</span>;</li>\n      <li>\n        <span class=\"list-set-name\">Antipyretic</span></li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F11426603\" class=\"block don drugH1Div\"><span class=\"drugH1\">Dosing: Neonatal</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Fever:</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Oral: Limited data available:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">GA 28 to 32 weeks: 10 to 12 mg/kg/dose every 6 to 8 hours; maximum daily dose: 40 mg/kg/<b>day</b> (Anand 2001; Anand 2002)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">GA 33 to 37 weeks or term neonates &lt;10 days: 10 to 15 mg/kg/dose every 6 hours; maximum daily dose: 60 mg/kg/<b>day</b> (Anand 2001; Anand 2002)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Term neonates &ge;10 days: 10 to 15 mg/kg/dose every 4 to 6 hours (Anand 2001; Anand 2002); do not exceed 5 doses in 24 hours; maximum daily dose: 75 mg/kg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">IV:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">GA 28 to &lt;32 weeks:  Limited data available: <b>Note:</b> Some experts do not recommend the use of IV acetaminophen in premature neonates &lt;32 weeks PMA until pharmacokinetic and pharmacodynamic studies have been conducted in this age group (van den Anker 2011).</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Loading dose (Allegaert 2007; Bartocci 2007): 20 mg/kg/dose</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Maintenance dose (Allegaert 2007; Allegaert 2011; Bartocci 2007): 10 mg/kg/dose every 12 hours; some suggest 7.5 mg/kg/dose every 8 hours; maximum daily dose: 22.5 mg/kg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">GA &ge;32 weeks:</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Manufacturer's labeling:</p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">PNA &le;4 weeks: 12.5 mg/kg/dose every 6 hours; maximum daily dose: 50 mg/kg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">PNA &gt;4 weeks: 15 mg/kg/dose every 6 hours; maximum daily dose: 60 mg/kg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Alternate dosing:</p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">Loading dose (Allegaert 2007; Bartocci 2007): 20 mg/kg/dose</p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">Maintenance dose (Allegaert 2007; Allegaert 2011; Bartocci 2007):</p>\n    <p style=\"text-indent:-2em;margin-left:12em;\">PMA 32 weeks: 10 mg/kg/dose every 12 hours; some suggest 7.5 mg/kg/dose every 8 hours; maximum daily dose: 22.5 mg/kg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:12em;\">PMA 33 to 36 weeks: 10 mg/kg/dose every 8 hours; some suggest 7.5 to 10 mg/kg/dose every 6 hours; maximum daily dose: 40 mg/kg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:12em;\">PMA &ge;37 weeks: 10 mg/kg/dose every 6 hours; maximum daily dose: 40 mg/kg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Rectal: Limited data available:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">GA 28 to 32 weeks: 20 mg/kg/dose every 12 hours; maximum daily dose: 40 mg/kg/<b>day</b> (Anand 2001; Anand 2002)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">GA 33 to 37 weeks or term neonates &lt;10 days: Loading dose: 30 mg/kg; then 15 mg/kg/dose every 8 hours; maximum daily dose: 60 mg/kg/<b>day</b> (Anand 2001; Anand 2002)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Term infants &ge;10 days: Loading dose: 30 mg/kg; then 20 mg/kg/dose every 6 to 8 hours (Anand 2001; Anand 2002); do not exceed 5 doses in 24 hours; maximum daily dose: 75 mg/kg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Pain: </b>Limited data available:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Oral:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">GA 28 to 32 weeks: 10 to 12 mg/kg/dose every 6 to 8 hours; maximum daily dose: 40 mg/kg/<b>day</b> (Anand 2001; Anand 2002)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">GA 33 to 37 weeks or term neonates &lt;10 days: 10 to 15 mg/kg/dose every 6 hours; maximum daily dose: 60 mg/kg/<b>day</b> (Anand 2001; Anand 2002)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Term neonates &ge;10 days: 10 to 15 mg/kg/dose every 4 to 6 hours (Anand 2001; Anand 2002); do not exceed 5 doses in 24 hours; maximum daily dose: 75 mg/kg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">IV: Efficacy results variable; optimal dose not established; <b>Note:</b> Some experts do not recommend the use of IV acetaminophen in premature neonates &lt;32 weeks PMA until pharmacokinetic and pharmacodynamic studies have been conducted in this age group (van den Anker 2011).</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Loading dose (Allegaert 2007; Bartocci 2007): 20 mg/kg/dose</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Maintenance dose (Allegaert 2007; Allegaert 2011; Bartocci 2007):</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">PMA 28 to 32 weeks: 10 mg/kg/dose every 12 hours; some suggest 7.5 mg/kg/dose every 8 hours; maximum daily dose: 22.5 mg/kg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">PMA 33 to 36 weeks: 10 mg/kg/dose every 8 hours; some suggest 7.5 to 10 mg/kg/dose every 6 hours; maximum daily dose: 40 mg/kg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">PMA &ge;37 weeks: 10 mg/kg/dose every 6 hours; maximum daily dose: 40 mg/kg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">\n      <b>Note</b>: Manufacturer neonatal pharmacokinetic data suggests that 7.5 mg/kg/dose every 6 hours produces a similar pharmacokinetic exposure as standard dosing in children &ge;2 years.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Rectal:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">GA 28 to 32 weeks: 20 mg/kg/dose every 12 hours; maximum daily dose: 40 mg/kg/<b>day</b>  (Anand 2001; Anand 2002)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">GA 33 to 37 weeks or term neonates &lt;10 days: Loading dose: 30 mg/kg; then 15 mg/kg/dose every 8 hours; maximum daily dose: 60 mg/kg/<b>day</b> (Anand 2001; Anand 2002)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Term infants &ge;10 days: Loading dose: 30 mg/kg; then 20 mg/kg/dose every 6 to 8 hours (Anand 2001; Anand 2002); do not exceed 5 doses in 24 hours; maximum daily dose: 75 mg/kg/<b>day</b></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1050742\" class=\"block dos drugH1Div\"><span class=\"drugH1\">Dosing: Usual</span><p>(For additional information <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">see &quot;Acetaminophen (paracetamol): Drug information&quot;</a>)</p>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Note:</b> In 2011, McNeil Consumer Healthcare reduced the maximum daily doses and increased the dosing interval on the labeling of some of their acetaminophen OTC products used in older pediatric patients (usually children &ge;12 years and adolescents) and adults in an attempt to protect consumers from inadvertent overdoses. For example, the maximum daily dose of  Extra Strength Tylenol OTC and Regular Strength Tylenol OTC were decreased to 3,000 mg/day and 3,250 mg/day respectively, and the dosing interval for Extra Strength Tylenol OTC was increased.  Health care professionals may still prescribe or recommend the 4 g adult daily maximum to patients &ge;12 years of age (but are advised to use their own discretion and clinical judgment) (McNeil Consumer Healthcare 2014).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Pediatric: <b>Note:</b> Oral liquids are available in multiple concentrations (eg, 160 mg/5 mL, 500 mg/5 mL and 500 mg/15 mL); precautions should be taken to verify and avoid confusion between the different concentrations; dose should be clearly presented as &quot;mg&rdquo;</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Pain (mild to moderate) or fever: Note:</b> Limit acetaminophen dose from all sources (prescription and OTC); maximum daily dose of acetaminophen should be limited to &le;75 mg/kg/day in &le;5 divided doses and not to exceed 4,000 mg/day for most products although some formulations suggest lower maximum daily dosing (see dosing information for further detail):</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Oral: <b>Note:</b> With OTC use, should not exceed recommended treatment duration unless directed by health care provider; for  fever: 3 days (all ages); pain (excluding sore throat): Children &ge;12 years and adolescents: 10 days, children: 5 days, or infants: 3 days; sore throat in children: 2 days</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Weight-directed dosing: Infants, Children, and Adolescents: 10 to 15 mg/kg/dose every 4 to 6 hours as needed (American Pain Society 2008; Kliegman 2011; Sullivan 2011); do not exceed 5 doses in 24 hours; maximum daily dose: 75 mg/kg/<b>day</b> not to exceed 4,000 mg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Fixed dosing:</p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">Oral suspension, chewable tablets: Infants and Children &lt;12 years: Consult specific product formulations for appropriate age groups. See table; use of weight to select dose is preferred; if weight is not available, then use age; doses may be repeated every 4 hours; maximum: 5 doses/day</p>\n    <table border=\"1\" rules=\"all\" frame=\"border\">\n      <caption style=\"text-align:center;\">Acetaminophen Dosing (Oral)</caption>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <thead valign=\"middle\">\n        <tr>\n          <th colspan=\"2\" valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">Weight (preferred)<sup>A</sup></p></th>\n          <th rowspan=\"2\" valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">Age</p></th>\n          <th rowspan=\"2\" valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">Dosage</p>\n            <p style=\"text-indent:0em;\">(mg)</p></th></tr>\n        <tr>\n          <th valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">kg</p></th>\n          <th valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">lbs</p></th></tr></thead>\n      <tfoot valign=\"middle\">\n        <tr>\n          <td colspan=\"4\" align=\"left\">\n            <p style=\"text-indent:0em;\">\n              <sup>A</sup>Manufacturer&rsquo;s recommendations are based on weight in pounds (OTC labeling); weight in kg listed here is derived from pounds and rounded; kg weight listed also is adjusted to allow for continuous weight ranges in kg. OTC labeling instructs consumer to consult with physician for dosing instructions in infants and children under 2 years of age.</p></td></tr></tfoot>\n      <tbody valign=\"middle\">\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">2.7 to 5.3</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">6 to 11</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">0 to 3 mo</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">40</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">5.4 to 8.1</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">12 to 17</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">4 to 11 mo</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">80</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">8.2 to 10.8</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">18 to 23</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">1 to 2 y</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">120</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">10.9 to 16.3</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">24 to 35</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">2 to 3 y</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">160</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">16.4 to 21.7</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">36 to 47</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">4 to 5 y</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">240</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">21.8 to 27.2</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">48 to 59</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">6 to 8 y</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">320</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">27.3 to 32.6</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">60 to 71</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">9 to 10 y</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">400</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">32.7 to 43.2</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">72 to 95</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">11 y</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">480</p></td></tr></tbody></table>\n    \n    <p style=\"text-indent:-2em;margin-left:10em;\">Immediate release solid dosage formulations: <b>Note:</b> Actual OTC dosing recommendations may vary by product and/or manufacturer:</p>\n    <p style=\"text-indent:-2em;margin-left:12em;\">Children 6 to 11 years: 325 mg every 4 to 6 hours; maximum daily dose: 1,625 mg/<b>day</b>; <b>Note:</b> Do not use more than 5 days unless directed by a physician</p>\n    <p style=\"text-indent:-2em;margin-left:12em;\">Children &ge;12 years and Adolescents:</p>\n    <p style=\"text-indent:-2em;margin-left:14em;\">\n      <i>Regular strength:</i> 650 mg every 4 to 6 hours; maximum daily dose: 3,250 mg/<b>day</b> unless directed by a physician; under physician supervision daily doses &le;4,000 mg may be used</p>\n    <p style=\"text-indent:-2em;margin-left:14em;\">\n      <i>Extra strength: </i>1,000 mg every 6 hours; maximum daily dose: 3,000 mg/<b>day</b> unless directed by a physician; under physician supervision daily doses &le;4,000 mg may be used</p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">Extended release: Children &ge;12 years and Adolescents: 1,300 mg every 8 hours; maximum daily dose: 3,900 mg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">IV:</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Infants and Children &lt;2 years:</p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">Manufacturer&rsquo;s labeling: Fever: 15 mg/kg/dose every 6 hours; maximum daily dose: 60 mg/kg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">Alternate dosing: Limited data available: Pain and fever: 7.5 to 15 mg/kg/dose every 6 hours; maximum daily dose: 60 mg/kg/<b>day</b> (Wilson-Smith 2009)</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Children &ge;2 years and Adolescents:</p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">&lt;50 kg: 15 mg/kg/dose every 6 hours <b>or</b> 12.5 mg/kg/dose every 4 hours; maximum single dose: 15 mg/kg up to 750 mg; maximum daily dose: 75 mg/kg/<b>day</b> not to exceed 3,750 mg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">&ge;50 kg: 1,000 mg every 6 hours <b>or</b> 650 mg every 4 hours; maximum single dose: 1,000 mg; maximum daily dose: 4,000 mg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Rectal:</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Weight-directed dosing: Limited data available: Infants and Children &lt;12 years: 10 to 20 mg/kg/dose every 4 to 6 hours as needed;<b> do <span style=\"text-decoration: underline\">not</span> exceed 5 doses in 24 hours</b> (Kliegman 2011; Vernon 1979); maximum daily dose: 75 mg/kg/day</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Fixed dosing:</p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">Infants 6 to 11 months: 80 mg every 6 hours; maximum daily dose: 320 mg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">Infants and Children 12 to 36 months: 80 mg every 4 to 6 hours; maximum daily dose: 400 mg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">Children &gt;3  to 6 years: 120 mg every 4 to 6 hours; maximum daily dose: 600 mg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">Children &gt;6 up to 12 years: 325 mg every 4 to 6 hours; maximum daily dose: 1,625 mg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">Children &ge;12 years and Adolescents: 650 mg every 4 to 6 hours; maximum daily dose: 3,900 mg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Pain; peri-/postoperative management; adjunct to opioid therapy: </b></p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">IV:</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Infants and Children &lt;2 years: Limited data available: 7.5 to 15 mg/kg/dose every 6 hours; maximum daily dose: 60 mg/kg/<b>day</b> (Wilson-Smith, 2009)</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Children &ge;2 years and Adolescents:</p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">&lt;50 kg: 15 mg/kg/dose every 6 hours <b>or</b> 12.5 mg/kg/dose every 4 hours; maximum single dose: 15 mg/kg up to 750 mg; maximum daily dose: 75 mg/kg/<b>day</b> not to exceed 3,750 mg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">&ge;50 kg: 1,000 mg every 6 hours or 650 mg every 4 hours; maximum single dose: 1,000 mg; maximum daily dose: 4,000 mg/day</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Rectal: Limited data available: Children and Adolescents:</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Loading dose: 40 mg/kg for 1 dose, in most trials, the dose was administered postoperatively (Birmingham 2001; Capici 2008; Hahn 2000; Mireskandari 2011; Prins 2008; Riad 2007; Viitanen 2003); a maximum dose of 1,000 mg was most frequently reported. However, in one trial evaluating 24 older pediatric patients (all  patients &ge;25 kg; mean age: ~13 years), the data suggested that a dose of 1,000 mg does not produce therapeutic serum concentrations (target for study: &gt;10 mcg/mL) compared to a 40 mg/kg dose (up to~ 2,000 mg); the resultant C<sub>max</sub> was: 7.8 mcg/mL (1,000 mg dose group) vs 15.9 mcg/mL (40 mg/kg dose group). <b>Note:</b>  Therapeutic serum concentrations for analgesia have not been well-established (Howell 2003).</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Maintenance dose: 20 to 25 mg/kg/dose every 6 hours as needed for 2 to 3 days has been suggested if further pain control is needed postoperatively; maximum daily dose: 100 mg/kg/day; therapy longer than 5 days has not been evaluated  (Birmingham 2001; Hahn 2000; Prins 2008).</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">\n      <b>Note:</b> In the majority of trials, suppositories were not divided due to unequal distribution of drug within suppository; doses were rounded to the nearest mg amount using 1 or 2 suppositories of available product strengths.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">Adult: <b>Note:</b> Limit acetaminophen dose from all sources (prescription and OTC) to &lt;4 g/day. No dose adjustment required when converting between different acetaminophen formulations:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Pain or fever:</b></p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">IV:</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">&lt;50 kg: 15 mg/kg every 6 hours or 12.5 mg/kg every 4 hours; maximum single dose: 15 mg/kg up to 750 mg; maximum daily dose: 75 mg/kg/<b>day</b> (&le;3,750 mg/day)</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">&ge;50 kg: 1,000 mg every 6 hours or 650 mg every 4 hours; maximum single dose: 1,000 mg/dose; maximum daily dose: 4,000 mg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Oral:</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Immediate release: <b>Note:</b> Actual OTC dosing recommendations may vary by product and/or manufacturer: 325 to 650 mg every 4 to 6 hours or 1,000 mg 3 to 4 times/day; maximum daily dose: 4,000 mg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Extended release: 1,300 mg every 8 hours; maximum daily dose: 3,900 mg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Rectal: 325 to 650 mg every 4 to 6 hours or 1,000 mg 3 to 4 times daily; maximum daily dose: 4,000 mg/<b>day</b></p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">\n      <b>Dosing adjustment in renal impairment:</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">IV: Children &ge;2 years, Adolescents, and Adults:  CrCl &le;30 mL/minute: Use with caution; consider decreasing daily dose and extending dosing interval</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Oral (Aronoff 2007):</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Infants, Children, and Adolescents:</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">GFR &ge;10 mL/minute/1.73 m<sup>2</sup>: No adjustment required</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">GFR &lt;10 mL/minute/1.73 m<sup>2</sup>: Administer every 8 hours</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Intermittent hemodialysis or peritoneal dialysis: Administer every 8 hours</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">CRRT: No adjustments necessary</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Adults:</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">CrCl 10 to 50 mL/minute: Administer every 6 hours</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">CrCl &lt;10 mL/minute: Administer every 8 hours</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Intermittent hemodialysis or peritoneal dialysis: No adjustment necessary</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">CRRT: Administer every 6 hours</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dosing adjustment in hepatic impairment:</b> Use with caution. Limited, low-dose therapy is usually well-tolerated in hepatic disease/cirrhosis; however, cases of hepatotoxicity at daily acetaminophen dosages &lt;4,000 mg/day have been reported. Avoid chronic use in hepatic impairment.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129293\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling. [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Caplet, oral: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Cetafen Extra: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap Extra Strength: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap Extra Strength: 500 mg [scored]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pain Eze: 650 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol: 325 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Extra Strength: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Caplet, extended release, oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap Arthritis Pain: 650 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Midol Long Lasting Relief: 650 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol 8 HR Arthritis Pain: 650 mg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Capsule, oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap Extra Strength: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol: 325 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Extra Strength: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Injection, solution [preservative free]:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Ofirmev: 10 mg/mL (100 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Liquid, oral: 160 mg/5 mL (120 mL, 473 mL); 500 mg/5 mL (240 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap Extra Strength: 500 mg/5 mL (237 mL) [contains propylene glycol, sodium 9 mg/15 mL, sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Q-Pap Children's: 160 mg/5 mL (118 mL [DSC], 473 mL [DSC]) [ethanol free; contains propylene glycol, sodium 2 mg/5 mL, sodium benzoate; cherry flavor, grape flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Silapap Children's: 160 mg/5 mL (118 mL, 237 mL, 473 mL) [ethanol free, sugar free; contains propylene glycol, sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Extra Strength: 500 mg/15 mL (240 mL [DSC]) [ethanol free; contains propylene glycol, sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Solution, oral: 160 mg/5 mL (5 mL, 10 mL, 20 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pain &amp; Fever Children's: 160 mg/5 mL (118 mL, 473 mL) [ethanol free, sugar free; contains propylene glycol, sodium 1 mg/5 mL, sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Solution, oral [drops]: 80 mg/0.8 mL (15 mL [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Little Fevers: 80 mg/mL (30 mL [DSC]) [dye free, ethanol free, gluten free; contains propylene glycol, sodium benzoate; berry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Q-Pap Infants': 80 mg/0.8 mL (15 mL [DSC]) [ethanol free; contains propylene glycol; fruit flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Silapap Infants': 80 mg/0.8 mL (15 mL [DSC], 30 mL [DSC]) [ethanol free; contains propylene glycol, sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Suppository, rectal: 120 mg (12s); 325 mg (12s); 650 mg (12s)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Acephen: 120 mg (12s, 50s, 100s); 325 mg (6s, 12s, 50s, 100s); 650 mg (12s, 50s, 100s)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">FeverAll Adults: 650 mg (50s)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">FeverAll Children's: 120 mg (6s, 50s)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">FeverAll Infants': 80 mg (6s, 50s)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">FeverAll Junior Strength: 325 mg (6s, 50s)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Suspension, oral: 160 mg/5 mL (5 mL, 10.15 mL, 20.3 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap Children's: 160 mg/5 mL (118 mL) [ethanol free; contains propylene glycol, sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap Infants': 160 mg/5 mL (59 mL [DSC]) [dye free, ethanol free; contains propylene glycol, sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Nortemp Children's: 160 mg/5 mL (118 mL) [ethanol free; contains propylene glycol, sodium benzoate; cotton candy flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pain &amp; Fever Children's: 160 mg/5 mL (60 mL) [ethanol free; contains propylene glycol, sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Q-Pap Children's: 160 mg/5 mL (118 mL [DSC]) [ethanol free; contains sodium 2 mg/5 mL, sodium benzoate; bubblegum flavor, cherry flavor, grape flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Children's: 160 mg/5 mL (120 mL) [dye free, ethanol free; contains propylene glycol, sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Children's: 160 mg/5 mL (120 mL) [ethanol free; contains propylene glycol, sodium 2 mg/5 mL, sodium benzoate; bubblegum flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Children's: 160 mg/5 mL (60 mL, 120 mL) [ethanol free; contains propylene glycol, sodium 2 mg/5 mL, sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Children's: 160 mg/5 mL (120 mL) [ethanol free; contains propylene glycol, sodium 2 mg/5 mL, sodium benzoate; grape flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Children's: 160 mg/5 mL (120 mL) [ethanol free; contains propylene glycol, sodium 2 mg/5 mL, sodium benzoate; strawberry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Infants': 160 mg/5 mL (60 mL) [ethanol free; contains propylene glycol, sodium benzoate; grape flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Syrup, oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Triaminic Children's Fever Reducer Pain Reliever: 160 mg/5 mL (118 mL) [contains benzoic acid, sodium 6 mg/5 mL; bubblegum flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Triaminic Children's Fever Reducer Pain Reliever: 160 mg/5 mL (118 mL) [contains sodium 5 mg/5 mL, sodium benzoate; grape flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Tablet, oral: 325 mg, 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Aspirin Free Anacin Extra Strength: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Cetafen: 325 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap: 325 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap Extra Strength: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Non-Aspirin Pain Reliever: 325 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pharbetol: 325 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pharbetol Extra Strength: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Q-Pap: 325 mg [scored] [DSC]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Q-Pap Extra Strength: 500 mg [scored] [DSC]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol: 325 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Extra Strength: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Valorin: 325 mg [sugar free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Valorin Extra: 500 mg [sugar free]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Tablet, chewable, oral: 80 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap Children's: 80 mg [fruit flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Tablet, dispersible, oral: 80 mg, 160 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap Children's: 80 mg [bubblegum flavor] [DSC]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap Children's: 80 mg [grape flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Jr. Meltaways: 160 mg [bubblegum flavor] [DSC]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Jr. Meltaways: 160 mg [grape flavor] [DSC]</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129278\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Availability (US)</span>\n    <p style=\"text-indent:0em;display:inline\">Yes: Excludes extended release products; injectable formulation</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F49212230\" class=\"block prod-avail drugH1Div\"><span class=\"drugH1\">Product Availability</span>\n    <p style=\"text-indent:0em;display:inline\">Ofirmev 100 mL IV bag formulation: FDA approved November 2016; availability anticipated in the second quarter of 2017.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1050752\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Oral: Administer with food to decrease GI upset; shake drops and suspension well before use; do not crush or chew extended release products </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Parenteral: For IV infusion only. May administer undiluted over 15 minutes. Use within 6 hours of opening vial or transferring to another container. Discard any unused portion; single-use vials only. </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Rectal: Remove wrapper; insert suppository well up into the rectum.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129313\" class=\"block sts drugH1Div\"><span class=\"drugH1\">Storage/Stability</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Injection: Store intact vials and bags at  20&deg;C to 25&deg;C (68&deg;F to 77&deg;F); do not refrigerate or freeze. Use within 6 hours of penetrating vial/bag or transferring to another container. Discard any unused portion.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Oral formulations: Store at 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F); avoid excessive heat (20&deg;C [104&deg;F]). Avoid high humidity (chewable tablets).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Suppositories: Store at 2&deg;C to 27&deg;C (25&deg;F to 80&deg;F); do not freeze.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1050751\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Immediate release:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Oral suspension, chewable tablets: Relief of minor aches and pains due to the common cold, flu, sore throat, headaches, and toothaches; reduction of fever (All indications: OTC products: FDA approved in infants and children &lt;12 years; consult specific product formulations for appropriate age groups)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Caplet/tablet: Relief of minor aches and pains due to the common cold, headaches, minor pain of arthritis, backache, menstrual cramps, muscle aches, and toothaches (All indications: OTC products: FDA approved in ages &ge;6 years and adults; consult specific product formulation for appropriate age group)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Extended release: Relief of minor aches and pains due to the common cold, headaches, backache, muscle aches, menstrual cramps, toothaches, and minor pain of arthritis; reduction of fever (All indications: OTC products: FDA approved in ages &ge;12 or 18 years and adults; consult specific product formulations for appropriate age groups)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Parenteral: Reduction of fever (FDA approved in pediatric patients [age not specified] and adults); treatment of mild to moderate pain (FDA approved in ages &ge;2 years and adults); treatment of moderate to severe pain when combined with opioid analgesia (FDA approved in ages &ge;2 years and adults)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Rectal: Relief of minor aches, pains, and headaches; reduction of fever (All indications: OTC products: FDA approved in ages &ge;6 months and adults; consult specific product formulation for appropriate age group); has also been used for management of postoperative pain</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129376\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues: </span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Acephen may be confused with AcipHex</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Acetaminophen may be confused with acetazolamide</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">FeverALL may be confused with Fiberall </p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Triaminic Children's Fever Reducer Pain Reliever may be confused with Triaminic cough and cold products</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tylenol may be confused with atenolol, timolol, Tylenol PM, Tylox</p>\n        <p style=\"text-indent:-2em;margin-left:4em;margin-top:2em;text-align:justify;\">Infusion bottles of ropivacaine and IV acetaminophen look similar. Potentially fatal mix-ups have been reported in which a glass bottle of Naropin was mistaken for Ofirmev in perioperative areas.</p></div>\r\n</div>\r\n\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Other safety concerns:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Duplicate therapy issues: This product contains acetaminophen, which may be a component of combination products. Do not exceed the maximum recommended daily dose of acetaminophen.</p>\n        <p style=\"text-indent:-2em;margin-left:4em;\">Infant concentration change: All children&rsquo;s and infant acetaminophen products are available as 160 mg/5 mL. Some remaining infant concentrated solutions of 80 mg/0.8 mL and 100 mg/mL may still be available on pharmacy shelves or in patient homes. Check concentrations closely prior to administering or dispensing and verify concentration available to patients prior to recommending a dose (November 2011).</p>\n        <p style=\"text-indent:-2em;margin-left:4em;\">Injection: Reports of 10-fold overdose errors using the parenteral product have occurred in the U.S. and Europe; calculation of doses in &quot;mg&quot; and subsequent administration of the dose in &quot;mL&quot; using the commercially available concentration of 10 mg/mL contributed to these errors. Expressing doses as mg <b>and</b> mL, as well as pharmacy preparation of doses,  may decrease error potential (Dart, 2012; ISMP, 2012).</p></div>\r\n</div>\r\n\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">International issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Depon [Greece] may be confused with Depen brand name for penicillamine [US]; Depin brand name for  nifedipine [India]; Dipen brand name for diltiazem [Greece]</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Duorol [Spain] may be confused with Diuril brand name for chlorothiazide [US, Canada] </p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Paralen [Czech Republic] may be confused with Aralen brand name for chloroquine [US, Mexico]</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129374\" class=\"block arm drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Oral, Rectal:</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Dermatologic: Skin rash</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Endocrine &amp; metabolic: Decreased serum bicarbonate, decreased serum calcium, decreased serum sodium, hyperchloremia, hyperuricemia, increased serum glucose</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Genitourinary: Nephrotoxicity (with chronic overdose)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Hematologic &amp; oncologic: Anemia, leukopenia, neutropenia, pancytopenia</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Hepatic: Increased serum alkaline phosphatase, increased serum bilirubin</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Hypersensitivity: Hypersensitivity reaction (rare)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Renal: Hyperammonemia, renal disease (analgesic)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>IV: </b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Cardiovascular: Hypertension, hypotension, peripheral edema (adults), tachycardia</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Central nervous system: Agitation (neonates, infants, children, and adolescents), anxiety (adults), fatigue (adults), headache (more common in adults), insomnia (adults), trismus (adults)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Dermatologic: Pruritus (neonates, infants, children, and adolescents), skin rash</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Endocrine &amp; metabolic: Hypervolemia, hypoalbuminemia (neonates, infants, children, and adolescents), hypokalemia, hypomagnesemia (neonates, infants, children, and adolescents), hypophosphatemia (neonates, infants, children, and adolescents)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Gastrointestinal: Abdominal pain, constipation (neonates, infants, children, and adolescents), diarrhea (neonates, infants, children, and adolescents), nausea (more common in adults), vomiting (more common in adults)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Genitourinary: Oliguria (neonates, infants, children, and adolescents)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Hematologic &amp; oncologic: Anemia</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Hepatic: Increased serum transaminases</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Local: Pain at injection site</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Neuromuscular &amp; skeletal: Limb pain, muscle spasm</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Ophthalmic: Periorbital edema</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Respiratory: Abnormal breath sounds (adults), atelectasis (neonates, infants, children, and adolescents), dyspnea (adults), hypoxia, pleural effusion (neonates, infants, children, and adolescents), pulmonary edema (neonates, infants, children, and adolescents), stridor (adults), wheezing (adults)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Miscellaneous: Fever (neonates, infants, children, and adolescents)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Rare but important or life-threatening: Anaphylaxis, hypersensitivity reaction</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129300\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Injection: Hypersensitivity to acetaminophen or any component of the formulation; severe hepatic impairment or severe active liver disease</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">OTC labeling: When used for self-medication, do not use with other drug products containing acetaminophen or if allergic to acetaminophen or any of the inactive ingredients</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129282\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Hepatotoxicity: Injection:<b> [US Boxed Warning]. Acetaminophen has been associated with acute liver failure, at times resulting in liver transplant and death. Hepatotoxicity is usually associated with excessive acetaminophen intake and often involves more than one product that contains acetaminophen.</b> Do not exceed the maximum recommended daily dose (&gt;4 g daily in adults). In addition, chronic daily dosing may also result in liver damage in some patients.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Hypersensitivity/anaphylactic reactions: Hypersensitivity and anaphylactic reactions have been reported; discontinue immediately if symptoms of allergic or hypersensitivity reactions occur.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Skin reactions: Serious and potentially fatal skin reactions, including  acute generalized exanthematous pustulosis (AGEP), Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN) have occurred rarely with acetaminophen use. Discontinue therapy at the first appearance of  skin rash.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Ethanol use: Use with caution in patients with alcoholic liver disease; consuming &ge;3 alcoholic drinks/day may increase the risk of liver damage.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; G6PD deficiency: Use with caution in patients with known G6PD deficiency.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Hepatic impairment: Use with caution in patients with hepatic impairment or active liver disease; use of the IV formulation is contraindicated in patients with severe hepatic impairment or severe active liver disease.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Hypovolemia: Use the IV formulation with caution in patients with severe hypovolemia (eg, due to dehydration or blood loss).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Malnutrition: Use with caution in patients with chronic malnutrition.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Renal impairment: Use with caution in patients with severe renal impairment; consider dosing adjustments.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Aspartame: Some products may contain aspartame, which is metabolized to phenylalanine and must be avoided (or used with caution) in patients with phenylketonuria.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Benzyl alcohol and derivatives: Some dosage forms may contain benzyl alcohol and/or sodium benzoate/benzoic acid; benzoic acid (benzoate) is a metabolite of benzyl alcohol;  large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension and cardiovascular collapse (AAP [&quot;Inactive&quot; 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol and/or benzyl alcohol derivative with caution in neonates.  See manufacturer&rsquo;s labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Injection: <b>[US Boxed Warning]: Take care to avoid dosing errors; ensure that the dose in mg is not confused with mL, dosing in patients &lt;50 kg is based on body weight, infusion pumps are properly programmed, and total daily dose of acetaminophen from all sources does not exceed the maximum daily limits.</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Polysorbate 80: Some dosage forms may contain polysorbate 80 (also known as Tweens). Hypersensitivity reactions, usually a delayed reaction, have been reported following exposure to pharmaceutical products containing polysorbate 80 in certain individuals (Isaksson, 2002; Lucente 2000; Shelley, 1995). Thrombocytopenia, ascites, pulmonary deterioration, and renal and hepatic failure have been reported in premature neonates after receiving parenteral products containing polysorbate 80 (Alade, 1986; CDC, 1984). See manufacturer&rsquo;s labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Propylene glycol: Some dosage forms may contain propylene glycol; large amounts are potentially toxic and have been associated hyperosmolality, lactic acidosis, seizures and respiratory depression; use caution (AAP [&quot;Inactive&quot; 1997]; Zar, 2007).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Dosage limit: Limit acetaminophen dose from all sources (prescription, OTC, combination products) and all routes of administration (IV, oral, rectal) to &lt;4 g/day (adults). </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Self-medication (OTC use): When used for self-medication, patients should be instructed to contact health care provider if symptoms get worse or new symptoms appear, redness or swelling is present in the painful area, fever lasts &gt;3 days (all ages), or pain (excluding sore throat) lasts longer than: Adults: 10 days, Children and Adolescents: 5 days, Infants: 3 days. When treating children with sore throat, if sore throat is severe, persists for &gt;2 days, or is followed by fever, rash, headache, nausea, or vomiting, consult health care provider immediately.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F26522735\" class=\"block add-pediatric-warn-info drugH1Div\"><span class=\"drugH1\">Warnings: Additional Pediatric Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Prophylactic use of acetaminophen to reduce fever and discomfort associated vaccination is not recommended by the Advisory Committee on Immunization Practices (ACIP). Additionally, the ACIP does not recommend prophylactic acetaminophen to reduce risk of febrile seizure in infants and children with or without a history of febrile seizures. Antipyretics have not been shown to prevent febrile seizures (NCIRD/ACIP 2011). One study reported that routine prophylactic administration of acetaminophen to prevent fever prior to vaccination decreased the immune response of some vaccines; in the trial evaluating 459 infants (including 226 who received acetaminophen), antibody geometric mean concentrations (GMCs) for targeted vaccine immune response markers were lower in significantly more infants in the acetaminophen group compared with control. Before the booster dose, children who received prophylactic acetaminophen had lower antibody GMCs for all vaccine serotypes than children in the control group; this effect persisted after boosting even in the absence of additional acetaminophen doses. The clinical significance of this reduction in immune response has not been established (Prymula 2009). Antipyretics may be used to treat fever or discomfort following vaccination (NCIRD/ACIP 2011).</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">Some dosage forms may contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures and respiratory depression; use caution (AAP, 1997; Shehab, 2009).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129365\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Substrate</b> of CYP1A2 (minor), CYP2A6 (minor), CYP2C9 (minor), CYP2D6 (minor), CYP2E1 (minor), CYP3A4 (minor); <b>Note:</b> Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129287\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=13028&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Alcohol (Ethyl): May enhance the hepatotoxic effect of Acetaminophen.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Barbiturates: May increase the metabolism of Acetaminophen. This may 1) diminish the effect of acetaminophen; and 2) increase the risk of liver damage.<b> Exceptions: </b>Amobarbital; Butabarbital; Butalbital; Methohexital; PENTobarbital; Secobarbital; Thiopental.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Busulfan: Acetaminophen may increase the serum concentration of Busulfan. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">CarBAMazepine: May increase the metabolism of Acetaminophen. This may 1) diminish the effect of acetaminophen; and 2) increase the risk of liver damage.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cholestyramine Resin: May decrease the absorption of Acetaminophen. Effect is minimal if cholestyramine is administered 1 hour after acetaminophen.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dapsone (Topical): May enhance the adverse/toxic effect of Methemoglobinemia Associated Agents.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dasatinib: Acetaminophen may enhance the hepatotoxic effect of Dasatinib. Dasatinib may increase the serum concentration of Acetaminophen. <i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Fosphenytoin-Phenytoin: May decrease the serum concentration of Acetaminophen. Specifically, serum concentrations of acetaminophen may be decreased (leading to decreased efficacy), but the formation of the toxic N-acetyl-p-benzoquinone imine (NAPQI) metabolite may be increased (leading to increased hepatotoxicity).<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Imatinib: Acetaminophen may enhance the hepatotoxic effect of Imatinib. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Isoniazid: May enhance the adverse/toxic effect of Acetaminophen.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">LamoTRIgine: Acetaminophen may decrease the serum concentration of LamoTRIgine. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">MetyraPONE: May increase the serum concentration of Acetaminophen. More importantly, by inhibiting the conjugative metabolism of acetaminophen, metyrapone may shift the metabolism towards the oxidative route that produces a hepatotoxic metabolite.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Mipomersen: Acetaminophen may enhance the hepatotoxic effect of Mipomersen. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Nitric Oxide: May enhance the adverse/toxic effect of Methemoglobinemia Associated Agents. Combinations of these agents may increase the likelihood of significant methemoglobinemia. Management: Monitor patients for signs of methemoglobinemia (e.g., hypoxia, cyanosis) when nitric oxide is used in combination with other agents associated with development of methemoglobinemia.  Avoid lidocaine/prilocaine.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Phenylephrine (Systemic): Acetaminophen may increase the serum concentration of Phenylephrine (Systemic). <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Prilocaine: Methemoglobinemia Associated Agents may enhance the adverse/toxic effect of Prilocaine. Combinations of these agents may increase the likelihood of significant methemoglobinemia.  Management: Monitor patients for signs of methemoglobinemia (e.g., hypoxia, cyanosis) when prilocaine is used in combination with other agents associated with development of methemoglobinemia.  Avoid lidocaine/prilocaine in infants receiving such agents.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Probenecid: May increase the serum concentration of Acetaminophen. Probenecid may also limit the formation of at least one major non-toxic metabolite, possibly increasing the potential for formation of the toxic NAPQI metabolite.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Sodium Nitrite: Methemoglobinemia Associated Agents may enhance the adverse/toxic effect of Sodium Nitrite. Combinations of these agents may increase the likelihood of significant methemoglobinemia. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">SORAfenib: Acetaminophen may enhance the hepatotoxic effect of SORAfenib. SORAfenib may increase the serum concentration of Acetaminophen. <i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Tetracaine (Topical): May enhance the adverse/toxic effect of Methemoglobinemia Associated Agents.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Vitamin K Antagonists (eg, warfarin): Acetaminophen may enhance the anticoagulant effect of Vitamin K Antagonists. This appears most likely with daily acetaminophen doses exceeding 1.3 or 2 g/day for multiple consecutive days. <i> Risk C: Monitor therapy</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129314\" class=\"block foi drugH1Div\"><span class=\"drugH1\">Food Interactions</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Rate of absorption may be decreased when given with food. Management: Administer without regard to food.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5630924\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Acetaminophen crosses the placenta and can be detected in cord blood, newborn serum, and urine immediately after delivery (Levy 1975; Naga Rani 1989; Wang 1997). An increased risk of teratogenic effects has not been observed following maternal use of acetaminophen during pregnancy. Prenatal constriction of the ductus arteriosus has been noted in case reports following maternal use during the third trimester (Suhag 2008; Wood 2005). The use of acetaminophen in normal doses during pregnancy is not associated with an increased risk of miscarriage or still birth; however, an increase in fetal death or spontaneous abortion may be seen following maternal overdose if treatment is delayed (Li 2003; Rebordosa 2009; Riggs 1989). Frequent maternal use of acetaminophen during pregnancy may be associated with wheezing and asthma in early childhood (Perzanowki 2010).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129281\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Although not fully elucidated, the analgesic effects are believed to be due to activation of descending serotonergic inhibitory pathways in the CNS. Interactions with other nociceptive systems may be involved as well (Smith 2009). Antipyresis is produced from inhibition of the hypothalamic heat-regulating center.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129299\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics (Adult data unless noted)</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Note: With the exception of half-life, the pharmacokinetic profile in pediatric patients (0-18 years) is similar to adult patients.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Onset of action:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Oral: &lt;1 hour</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">IV: Analgesia: 5 to 10 minutes; Antipyretic: Within 30 minutes</p>\n    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">Peak effect: IV: Analgesic: 1 hour</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Duration:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">IV, Oral: Analgesia: 4 to 6 hours</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">IV: Antipyretic: &ge;6 hours</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Absorption: Primarily absorbed in small intestine (rate of absorption dependent upon gastric emptying); minimal absorption from stomach; varies by dosage form</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Distribution: ~1 L/kg at therapeutic doses </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Protein binding: 10% to 25% at therapeutic concentrations; 8% to 43% at toxic concentrations</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Metabolism: At normal therapeutic dosages, primarily hepatic metabolism to sulfate and glucuronide conjugates, while a small amount is metabolized by CYP2E1 to a highly reactive intermediate, N-acetyl-p-benzoquinone imine (NAPQI), which is conjugated rapidly with glutathione and inactivated to nontoxic cysteine and mercapturic acid conjugates. At toxic doses (as little as 4 g daily) glutathione conjugation becomes insufficient to meet the metabolic demand causing an increase in NAPQI concentrations, which may cause hepatic cell necrosis. Oral administration is subject to first pass metabolism.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Half-life elimination: Prolonged following toxic doses </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Neonates: 7 hours (range: 4 to 10 hours)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Infants: ~4 hours (range: 1 to 7 hours)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Children: 3 hours (range: 2 to 5 hours)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Adolescents: ~3 hours (range: 2 to 4 hours)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Adults: ~2 hours (range: 2 to 3 hours); may be slightly prolonged in severe renal insufficiency (CrCl&lt;30 mL/minute): 2 to 5.3 hours </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Time to peak, serum: Oral: Immediate release: 10 to 60 minutes (may be delayed in acute overdoses); IV: 15 minutes</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Excretion: Urine (&lt;5% unchanged; 60% to 80% as glucuronide metabolites; 20% to 30% as sulphate metabolites; ~8% cysteine and mercapturic acid metabolites) </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1050756\" class=\"block adi drugH1Div\"><span class=\"drugH1\">Additional Information</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>2 mg propacetamol (prodrug) = 1 mg paracetamol = 1 mg acetaminophen</b></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Acetaminophen (15 mg/kg/dose given orally every 6 hours for 24 hours) did <b>not</b> relieve the intraoperative or the immediate postoperative pain associated with neonatal circumcision; some benefit was seen 6 hours after circumcision (Howard, 1994).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">There is currently no scientific evidence to support alternating acetaminophen with ibuprofen in the treatment of fever (Mayoral, 2000).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Based on recommendations provided by the Food and Drug Administration (FDA), all over-the-counter (OTC) pediatric single-ingredient acetaminophen liquid products are now only available as a single concentration of 160 mg/5 mL; the transition began in 2011. The concentration 80 mg/0.8 mL is no longer available in the US. The recommended mg/kg dose is unaffected.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129302\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Capsules</b> (Tylenol Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">325 mg (20): $3.60</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Acetaminophen Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">80 mg (30): $1.37</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Mapap Childrens Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">160 mg (24): $2.10</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (ElixSure Fever/Pain Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">160 mg/5 mL (120 mL): $4.86</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Acetaminophen Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">160 mg/5 mL (473 mL): $7.95</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Mapap Acetaminophen Extra Str Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg/15 mL (237 mL): $4.19</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Acetaminophen Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">160 mg/5 mL (5 mL): $1.94</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Febrol Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">325 mg/5 mL (120 mL): $7.18</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Ofirmev Intravenous)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10 mg/mL (100 mL): $45.02</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suppository</b> (Acephen Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">120 mg (50): $30.30</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">325 mg (50): $32.75</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">650 mg (12): $8.48</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suppository</b> (FeverAll Adults Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">650 mg (50): $33.08</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suppository</b> (FeverAll Childrens Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">120 mg (6): $4.81</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suppository</b> (FeverAll Infants Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">80 mg (6): $4.81</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suppository</b> (FeverAll Junior Strength Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">325 mg (6): $4.81</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension</b> (Mapap Childrens Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">160 mg/5 mL (118 mL): $2.89</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension</b> (Nortemp Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">160 mg/5 mL (118 mL): $5.55</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension</b> (Tylenol Childrens Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">160 mg/5 mL (120 mL): $6.30</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension</b> (Tylenol Infants Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">160 mg/5 mL (60 mL): $8.86</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension</b> (Tylenol Infants Pain+Fever Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">160 mg/5 mL (30 mL): $5.36</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Syrup</b> (Triaminic Fever Reducer Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">160 mg/5 mL (59 mL): $4.85</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablet, controlled release</b> (Tylenol 8 Hour Arthritis Pain Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">650 mg (100): $11.59</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablet, controlled release</b> (Tylenol 8 Hour Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">650 mg (100): $11.59</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablet, orally-disintegrating</b> (Mapap Childrens Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">80 mg (30): $2.95</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Acetaminophen Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">325 mg (100): $1.86</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg (100): $2.61</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Healthy Mama Shake That Ache Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg (100): $5.70</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Mapap Extra Strength Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg (100): $5.69</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Pharbetol Extra Strength Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg (100): $2.97</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Pharbetol Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">325 mg (100): $2.25</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Tylenol Extra Strength Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg (100): $10.62</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Tylenol Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">325 mg (100): $5.48</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129304\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>A-Mol (TH);</li>\n      <li>Acamol (CL, IL, LI);</li>\n      <li>Acamol To-Go (IL);</li>\n      <li>Acamoli Baby (IL);</li>\n      <li>Acamoli Forte suppositories for Kids (IL);</li>\n      <li>Accelio (JP);</li>\n      <li>Acemol (VN);</li>\n      <li>ACET suppositories (SG);</li>\n      <li>Acetab (VN);</li>\n      <li>Acetalgin (CH);</li>\n      <li>Acetamol (IT);</li>\n      <li>Acicur-P (PY);</li>\n      <li>Adinol (CR, DO, GT, HN, MX, NI, SV);</li>\n      <li>Adol (EG, ET, JO, KW, LB, QA, SA);</li>\n      <li>Adolin (PA);</li>\n      <li>Adorem (CO);</li>\n      <li>Afebrin (HK);</li>\n      <li>Afebryl (LU);</li>\n      <li>Agap Fast (PL);</li>\n      <li>Agomol (TZ);</li>\n      <li>Alcocin (IN);</li>\n      <li>Alginox (EC);</li>\n      <li>Alvedon (SE);</li>\n      <li>Amadol (AU);</li>\n      <li>Ametrex (CO);</li>\n      <li>Amol (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);</li>\n      <li>Analgiser (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);</li>\n      <li>Analphen (MX);</li>\n      <li>Angela (TH);</li>\n      <li>Antalgic (ZW);</li>\n      <li>Antamol (JO);</li>\n      <li>Apacet (LI);</li>\n      <li>Apap (LI);</li>\n      <li>Apimol (ZW);</li>\n      <li>Aptamol (IN);</li>\n      <li>Arfen (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, MY, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);</li>\n      <li>Atamel (PE);</li>\n      <li>Avadol (MY);</li>\n      <li>Axcel (MY);</li>\n      <li>Ben-U-Ron (CH, PT);</li>\n      <li>ben-u-ron (HU);</li>\n      <li>Benuron (JP);</li>\n      <li>Betamol (ZW);</li>\n      <li>Biogesic (SG);</li>\n      <li>Biogesic Suspension (HK);</li>\n      <li>Biopain (PH);</li>\n      <li>Calapol (ID);</li>\n      <li>Calonal (JP);</li>\n      <li>Calpol (AE, BF, BH, BJ, CI, CY, EG, ET, GH, GM, GN, IE, IQ, IR, JO, JP, KE, KW, LB, LK, LR, LY, MA, ML, MR, MT, MU, MW, NE, NG, OM, PR, QA, SA, SC, SD, SI, SL, SN, SY, TN, TZ, UG, YE, ZM, ZW);</li>\n      <li>Causalon (AR);</li>\n      <li>Cemol (TH);</li>\n      <li>Cetal (ET);</li>\n      <li>Cetapain (ID);</li>\n      <li>Cetapyrin (LK);</li>\n      <li>Cetta (TH);</li>\n      <li>Champ Syrup (KR);</li>\n      <li>Children's Bufferin (CN);</li>\n      <li>Children's S Tylenol (KR);</li>\n      <li>Christamol (HK);</li>\n      <li>Claradol (MA);</li>\n      <li>Cotemp (TH);</li>\n      <li>Croix Blanche (LU);</li>\n      <li>Curpol (LU);</li>\n      <li>Dafalgan (BE, LU);</li>\n      <li>Dafalgan odis (LU);</li>\n      <li>Dailyal (LV);</li>\n      <li>Daleron (HR, SI);</li>\n      <li>Den-U-Ron (CN);</li>\n      <li>Denamol (TH);</li>\n      <li>Depon (TR);</li>\n      <li>Dirox (AR);</li>\n      <li>Dismifen (MX);</li>\n      <li>Dol-Stop (LU);</li>\n      <li>Dolan Infantil (GT, HN, NI, SV);</li>\n      <li>Dolex (UY);</li>\n      <li>Dolgesic (ES);</li>\n      <li>Doliprane (FR, IN, LB, MA);</li>\n      <li>Dolitabs (FR);</li>\n      <li>Dolomol (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);</li>\n      <li>Dolorol (ZA);</li>\n      <li>Dolprone (LU);</li>\n      <li>Doluvital (MX);</li>\n      <li>Dolviran (MX);</li>\n      <li>Dumin (LK);</li>\n      <li>Dymadon (AU);</li>\n      <li>Eferalhan (UA);</li>\n      <li>Efermol (PY);</li>\n      <li>Efferalgan (HR, HU, LT, LU, LV);</li>\n      <li>Efferalgan 500 (CR, DO, EE, GT, HN, NI, PA, SV);</li>\n      <li>Efferalganodis (FR);</li>\n      <li>Enelfa (LU);</li>\n      <li>Eterfix (ID);</li>\n      <li>Europain (HK);</li>\n      <li>Fast (BD);</li>\n      <li>Fbridol (ET);</li>\n      <li>Febridol (AU);</li>\n      <li>Febrile Free (PH);</li>\n      <li>Fervex (BR);</li>\n      <li>Fibralgin (HR);</li>\n      <li>Filanc (MX);</li>\n      <li>Fortolin (CN, HK);</li>\n      <li>Gelocatil (ES);</li>\n      <li>Geluprane 500 (FR);</li>\n      <li>Hedex (IE);</li>\n      <li>Hoemal (MY);</li>\n      <li>Ifimol (UA);</li>\n      <li>Kelvin (ET, LK);</li>\n      <li>Lekadol (HR);</li>\n      <li>Lemgrip (BE, LU);</li>\n      <li>Lonarid mono (LU);</li>\n      <li>Lotemp (TH);</li>\n      <li>Lupocet (HR);</li>\n      <li>Maccabimol (IL);</li>\n      <li>Mafidol (PE);</li>\n      <li>Medipyrin (SK);</li>\n      <li>Mejoralito Junior (MX);</li>\n      <li>Mejoralito Pedi&aacute;trico (MX);</li>\n      <li>Meldol (ZW);</li>\n      <li>Metagesic (PH);</li>\n      <li>Mexalen (AT, CZ, HU);</li>\n      <li>Minopan (KR);</li>\n      <li>Momentum (LU);</li>\n      <li>Mypara (TH);</li>\n      <li>Napafen (EC);</li>\n      <li>Napamol (ZA);</li>\n      <li>Napaton (TW);</li>\n      <li>Napran (PH);</li>\n      <li>Naprex (ID);</li>\n      <li>NEBS (JP);</li>\n      <li>Neuridon (LU);</li>\n      <li>Nordinet Infantil (MX);</li>\n      <li>Normotemp (EC);</li>\n      <li>Novadol (ZW);</li>\n      <li>Nufadol (ID);</li>\n      <li>Omnipap (PL);</li>\n      <li>Omol (QA);</li>\n      <li>Pacemol (KR);</li>\n      <li>Padolieve (IE);</li>\n      <li>Pamol (BH, DK, JO, NZ);</li>\n      <li>Pamol 650 (SG);</li>\n      <li>Panadol (AE, AU, BE, BF, BG, BH, BJ, CH, CI, CL, CN, CY, CZ, EE, EG, ES, ET, FI, FR, GB, GH, GM, GN, GR, HK, HU, ID, IE, IL, IQ, IR, IT, JO, KE, KR, KW, LB, LK, LR, LU, LV, LY, MA, ML, MR, MT, MU, MW, NE, NG, NL, NZ, OM, PE, PK, PL, PT, QA, RO, RU, SA, SC, SD, SG, SK, SL, SN, SY, TH, TN, TW, TZ, UA, UG, YE, ZM, ZW);</li>\n      <li>Panadol Actifast (MY, SG);</li>\n      <li>Panadol Extend (SG);</li>\n      <li>Panadol for Children (SG);</li>\n      <li>Panadon (HR);</li>\n      <li>Panadrex (ET);</li>\n      <li>Panamax (AU);</li>\n      <li>Panodil (DK, NO, SE);</li>\n      <li>Para-IV (PH);</li>\n      <li>Paracet (IS, NO, ZW);</li>\n      <li>Paracetamol (HR);</li>\n      <li>Paracetamol Pharmavit (HU);</li>\n      <li>Paracetamol-ratiopharm (LU);</li>\n      <li>Paracetol (LK);</li>\n      <li>Paracip (LV);</li>\n      <li>Paragin (TH);</li>\n      <li>Paralgin (AU);</li>\n      <li>Paralief (IE);</li>\n      <li>Paramol (IL, LB, RO, TW);</li>\n      <li>Paramol Kat Drops (IL);</li>\n      <li>Parapaed (DE);</li>\n      <li>Parapaed Junior (NZ);</li>\n      <li>Parapaed Six Plus (NZ);</li>\n      <li>Paratabs (IS);</li>\n      <li>Parcemol (HK);</li>\n      <li>Parcemol Forte (HK);</li>\n      <li>Parmol (HK);</li>\n      <li>Paromon (HK);</li>\n      <li>Parvid (PH);</li>\n      <li>Paximol (SG);</li>\n      <li>Pe-Tam (LU);</li>\n      <li>Pedipan (KR);</li>\n      <li>Penral-Night (KR);</li>\n      <li>Perdolan Mono (LU);</li>\n      <li>Perfalgan (AE, AT, BG, CH, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, IE, IL, IN, IS, IT, JO, KR, KW, LB, LT, MT, NZ, PL, PT, QA, RO, RU, SA, SE, SI, SK, TR, VN, ZA);</li>\n      <li>Perfusalgan (BE);</li>\n      <li>Pharmacen-M (MX);</li>\n      <li>Pinex (NO);</li>\n      <li>Pireta (ID);</li>\n      <li>Plicet (HR);</li>\n      <li>Poro (ID, MY, PH, SG, TH);</li>\n      <li>Portem (CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>Progesic (HK);</li>\n      <li>Raperon (KR);</li>\n      <li>Rapidene (LK);</li>\n      <li>Rapidol (CL, UA);</li>\n      <li>Reliv (SE);</li>\n      <li>Remedol (MT, PR, TR);</li>\n      <li>Revanin (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);</li>\n      <li>Rhinapen elixir (KR);</li>\n      <li>Rubophen (HU);</li>\n      <li>Salzone (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);</li>\n      <li>Sanmol (PH);</li>\n      <li>Sanmol Infusion (ID);</li>\n      <li>Saridon (CO);</li>\n      <li>Sedalito (MX);</li>\n      <li>Sedalmerck (CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>Selegesic (PH);</li>\n      <li>Sensamol (IL);</li>\n      <li>Setamol (HK);</li>\n      <li>Setopain (KR);</li>\n      <li>Setopain ER (KR);</li>\n      <li>Sinebriv (PL);</li>\n      <li>Sinedol (DO, MX);</li>\n      <li>Strimol (ZW);</li>\n      <li>Supadol mono (LU);</li>\n      <li>Suspen ER (KR);</li>\n      <li>Tafirol (PE);</li>\n      <li>Tamin (TZ);</li>\n      <li>Tamoliv (ID);</li>\n      <li>Tasmen (KR);</li>\n      <li>Tempol (MY);</li>\n      <li>Tempra (ID, JP, LU, MX);</li>\n      <li>Tempte (TW);</li>\n      <li>Teramol (PH);</li>\n      <li>Teramol Forte (PH);</li>\n      <li>Tipol (IE);</li>\n      <li>Toniker (TW);</li>\n      <li>Turpan (ID);</li>\n      <li>Tylenol (BR, CH, DE, JP, KR, MX, PH, PT, TH, VE);</li>\n      <li>Tylenol 8-hour (TH);</li>\n      <li>Tylenol Acetaminophen Extended Relief (CN);</li>\n      <li>Tylenol ER (KR);</li>\n      <li>Tylenol Extra Fuerte (PY);</li>\n      <li>Tylenol Forte (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);</li>\n      <li>Tylex (BB, BM, BS, BZ, CR, DO, GT, GY, HN, JM, MX, NI, PA, SR, SV, TT);</li>\n      <li>Umbral (EC);</li>\n      <li>Winadol (CO, VE);</li>\n      <li>Xcel (BD);</li>\n      <li>Xebramol (TH);</li>\n      <li>XL-Dol Infantil (MX);</li>\n      <li>Z-Mol (PY)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Alade SL, Brown RE, Paquet A. Polysorbate 80 and e-ferol toxicity. <i>Pediatrics</i>. 1986;77(4):593-597.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/3960626/pubmed\" target=\"_blank\" id=\"3960626\">3960626</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Allegaert K, Murat I, Anderson BJ. Not all intravenous paracetamol formulations are created equal...<i>Paediatr Anaesth</i>. 2007;17(8):811-812.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/17596233/pubmed\" target=\"_blank\" id=\"17596233\">17596233</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Allegaert K, Palmer GM, Anderson BJ. The pharmacokinetics of intravenous paracetamol in neonates: size matters most. <i>Arch Dis Child</i>. 2011;96(6):575-580.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/21317433/pubmed\" target=\"_blank\" id=\"21317433\">21317433</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    American Academy of Pediatrics Committee on Drugs. &quot;Inactive&quot; ingredients in pharmaceutical products: update (subject review). <i>Pediatrics</i>. 1997;99(2):268-278.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/9024461/pubmed\" target=\"_blank\" id=\"9024461\">9024461</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Anand KJ, International Evidence-Based Group for Neonatal Pain. Consensus statement for the prevention and management of pain in the newborn. <i>Arch Pediatr Adolesc Med</i>. 2001;155(2):173-180.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/11177093/pubmed\" target=\"_blank\" id=\"11177093\">11177093</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Anand KJ, Chair, International Evidence-Based Group for Neonatal Pain, personal correspondence, April 2002.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Anderson PO, Sauberan JB, Lane JR, et al, &ldquo;Hydrocodone Excretion Into Breast Milk: The First Two Reported Cases,&rdquo; <i>Breastfeed Med</i>, 2007, 2(1):10-4.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/17661614/pubmed\" target=\"_blank\" id=\"17661614\">17661614</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Anderson PO, Sauberan JB. Modeling drug passage into human milk. <i>Clin Pharmacol Ther</i>. 2016;100(1):42-52.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/27060684/pubmed\" target=\"_blank\" id=\"27060684\">27060684</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Aronoff GR, Bennett WM, Berns JS, et al. <i>Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children</i>, 5th ed. Philadelphia, PA: American College of Physicians; 2007.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Bartocci M, Lundeberg S. Intravenous paracetamol: the 'Stockholm Protocol' for postoperative analgesia of term and preterm neonates. <i>Paediatr Anaesth</i>. 2007;17(11):1120-1121.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/17897288/pubmed\" target=\"_blank\" id=\"17897288\">17897288</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Berlin CM Jr, Yaffe SJ, Ragni M. Disposition of acetaminophen in milk, saliva, and plasma of lactating women. <i>Pediatr Pharmacol (New York)</i>. 1980;1(2):135-141.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/7202185/pubmed\" target=\"_blank\" id=\"7202185\">7202185</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Birmingham PK, Tobin MJ, Fisher DM, et al. Initial and subsequent dosing of rectal acetaminophen in children: a 24-hour pharmacokinetic study of new dose recommendations. <i>Anesthesiology</i>. 2001;94(3):385-389.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/11374595/pubmed\" target=\"_blank\" id=\"11374595\">11374595</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Buck ML. Perioperative use of high-dose rectal acetaminophen. Pediatr Pharm. 2001; 7(9). Available at http://www.medscape.com/viewarticle/415082</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Capici F, Ingelmo PM, Davidson A, et al. Randomized controlled trial of duration of analgesia following intravenous or rectal acetaminophen after adenotonsillectomy in children. <i>Br J Anaesth</i>. 2008;100(2):251-255.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/18211998 /pubmed\" target=\"_blank\" id=\"18211998 \">18211998 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol - United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a href=\"http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm\" target=\"_blank\">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a><span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/6810084 /pubmed\" target=\"_blank\" id=\"6810084 \">6810084 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control and Prevention (CDC). Unusual syndrome with fatalities among premature infants: association with a new intravenous vitamin E product. <i>MMWR</i>. 1984;33(14):198-199. Available at <a href=\"http://www.cdc.gov/mmwr/preview/mmwrhtml/00000319.htm\" target=\"_blank\">http://www.cdc.gov/mmwr/preview/mmwrhtml/00000319.htm</a><span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/6423951/pubmed\" target=\"_blank\" id=\"6423951\">6423951</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Children's Tylenol meltaways chewable tablets (acetaminophen) [prescribing information]. Fort Washington, PA: McNeil-PPC, Inc; 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Children&rsquo;s Tylenol oral suspension liquid (acetaminophen) [prescribing information]. Fort Washington, PA: McNeil-PPC, Inc; 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Dart RC, Rumack BH. Intravenous acetaminophen in the United States: iatrogenic dosing errors. <i>Pediatrics</i>. 2012;129(2):349-353.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/22271694/pubmed\" target=\"_blank\" id=\"22271694\">22271694</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    FeverAll suppositories (acetaminophen) [prescribing information]. Lincolnton, NC: Actavis; 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      Frequently Asked Questions About New Dosing for Extra Strength Tylenol Products. Fort Washington, PA: McNeil-PPC, Inc; 2014. Available at http://www.tylenolprofessional.com/assets/v4/faqs-new-dosing.pdf</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Hahn TW, Henneberg SW, Holm-Knudsen RJ, et al. Pharmacokinetics of rectal paracetamol after repeated dosing in children. <i>Br J Anaesth</i>. 2000;85(4):512-519.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/11064607/pubmed\" target=\"_blank\" id=\"11064607\">11064607</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Howard CR, Howard FM, Weitzman ML. Acetaminophen analgesia in neonatal circumcision: the effect on pain. <i>Pediatrics</i>. 1994;93(4):641-646.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/8134222 /pubmed\" target=\"_blank\" id=\"8134222 \">8134222 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Howell TK, Patel D. Plasma paracetamol concentrations after different doses of rectal paracetamol in older children A comparison of 1 g vs. 40 mg x kg(-1). <i>Anaesthesia</i>. 2003;58(1):69-73.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/12523328 /pubmed\" target=\"_blank\" id=\"12523328 \">12523328 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Hurden EL, Harvey DL, Lewis PJ. Excretion of paracetamol in human breast milk, Neonatal Society Meeting Held on 4 July 1980 in Southampton. <i>Arch Dis Child. </i>1980; 55(12):969-972.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/21032602/pubmed\" target=\"_blank\" id=\"21032602\">21032602</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Infants' Tylenol oral suspension (acetaminophen) [prescribing information]. Fort Washington, PA: McNeil-PPC, Inc; 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Institute for Safe Medication Practices (ISMP). IV acetaminophen and overdoses in kids. ISMP Medication Safety Alert, April 19, 2012. Available at http://ismp.org/Newsletters/acutecare/issue.asp?dt=20120419 </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Isaksson M, Jansson L.Contact allergy to Tween 80 in an inhalation suspension. <i>Contact Dermatitis</i>. 2002;47(5):312-313.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/12534540 /pubmed\" target=\"_blank\" id=\"12534540 \">12534540 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ito S, Blajchman A, Stephenson M, Eliopoulos C, Koren G. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. <i>Am J Obstet Gynecol</i>. 1993;168(5):1393-1399.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/8498418/pubmed\" target=\"_blank\" id=\"8498418\">8498418</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ito S. Drug therapy for breast-feeding women. <i>N Engl J Med</i>. 2000;343(2):118-126.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/10891521/pubmed\" target=\"_blank\" id=\"10891521\">10891521</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Jr. Tylenol meltaways chewable tablets (acetaminophen) [prescribing information]. Fort Washington, PA: McNeil-PPC, Inc; 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kliegman RM, Stanton BF, St. Gemell JW, et al, eds. <i>Nelson Textbook of Pediatrics</i>. 19th ed. Philadelphia, PA: Saunders Elsevier; 2011.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Levy G, Garrettson LK, and Soda DM, &quot;Letter: Evidence of Placental Transfer of Acetaminophen,&quot; <i>Pediatrics</i>, 1975, 55(6):895.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/1134892/pubmed\" target=\"_blank\" id=\"1134892\">1134892</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Li DK, Liu L, and Odouli R, &quot;Exposure to Non-Steroidal Anti-inflammatory Drugs During Pregnancy and Risk of Miscarriage: Population Based Cohort Study,&quot; <i>BMJ</i>, 2003, 327(7411):368.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/12919986/pubmed\" target=\"_blank\" id=\"12919986\">12919986</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Lucente P, Iorizzo M, Pazzaglia M. Contact sensitivity to Tween 80 in a child. <i>Contact Dermatitis</i>. 2000;43(3):172.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/10985636 /pubmed\" target=\"_blank\" id=\"10985636 \">10985636 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Matheson I, Lunde PK, and Notarianni L, &quot;Infant Rash Caused by Paracetamol in Breast Milk?&quot; <i>Pediatrics</i>, 1985, 76(4):651-2.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/2931668/pubmed\" target=\"_blank\" id=\"2931668\">2931668</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Mayoral CE, Marino RV, Rosenfeld W, et al. Alternating antipyretics: is this an alternative? <i>Pediatrics</i>. 2000;105(5):1009-1012.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/10790455 /pubmed\" target=\"_blank\" id=\"10790455 \">10790455 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Mireskandari SM, Makarem J. Effect of rectal diclofenac and acetaminophen alone and in combination on postoperative pain after cleft palate repair in children. <i>J Craniofac Surg</i>. 2011;22(5):1955-1959.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/21959480 /pubmed\" target=\"_blank\" id=\"21959480 \">21959480 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Montgomery A, Hale TW, Academy Of Breastfeeding Medicine. ABM clinical protocol #15: analgesia and anesthesia for the breastfeeding mother, revised 2012. <i>Breastfeed Med</i>. 2012;7(6):547-553.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/23215911/pubmed\" target=\"_blank\" id=\"23215911\">23215911</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Naga Rani MA, Joseph T, and Narayanan R, &quot;Placental Transfer of Paracetamol,&quot; <i>J Indian Med Assoc</i>, 1989, 87(8):182-3.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/2621359/pubmed\" target=\"_blank\" id=\"2621359\">2621359</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    National Center for Immunization and Respiratory Diseases, Advisory Committee on Immunization Practices (NCIRD/ACIP). General recommendations on immunization --- recommendations of the Advisory Committee on Immunization Practices (ACIP). <i>MMWR Recomm Rep</i>. 2011;60(2):1-64.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/21293327 /pubmed\" target=\"_blank\" id=\"21293327 \">21293327 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Notarianni LJ, Oldham HG, and Bennett PN, &quot;Passage of Paracetamol Into Breast Milk and its Subsequent Metabolism by the Neonate,&quot; <i>Br J Clin Pharmacol</i>, 1987, 24(1):63-7.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/3620287/pubmed\" target=\"_blank\" id=\"3620287\">3620287</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ofirmev (acetaminophen) [package insert]. Hazelwood, MO: Mallinckrodt Hospital Products Inc; January 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Perzanowski MS, Miller RL, Tang D, et al, &quot;Prenatal Acetaminophen Exposure and Risk of Wheeze at Age 5 Years in an Urban Low-Income Cohort,&quot; <i>Thorax</i>, 2010, 65(2):118-23.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/19850963/pubmed\" target=\"_blank\" id=\"19850963\">19850963</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    &quot;Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain,&quot; 6th ed, Glenview, IL: American Pain Society, 2008.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Prins SA, Van Dijk M, Van Leeuwen P, et al. Pharmacokinetics and analgesic effects of intravenous propacetamol vs rectal paracetamol in children after major craniofacial surgery. <i>Paediatr Anaesth</i>. 2008;18(7):582-592.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/18482233 /pubmed\" target=\"_blank\" id=\"18482233 \">18482233 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Prymula R, Siegrist CA, Chlibek R, et al. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials. <i>Lancet</i>. 2009;374(9698):1339-1350.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/19837254 /pubmed\" target=\"_blank\" id=\"19837254 \">19837254 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Rebordosa C, Kogevinas M, Bech BH, et al, &quot;Use of Acetaminophen During Pregnancy and Risk of Adverse Pregnancy Outcomes,&quot; <i>Int J Epidemiol</i>, 2009, 38(3):706-14.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/19332503/pubmed\" target=\"_blank\" id=\"19332503\">19332503</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Riad W, Moussa A. Pre-operative analgesia with rectal diclofenac and/or paracetamol in children undergoing inguinal hernia repair. <i>Anaesthesia</i>. 2007;62(12):1241-1245.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/17991260 /pubmed\" target=\"_blank\" id=\"17991260 \">17991260 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Riggs BS, Bronstein AC, Kulig K, et al, &quot;Acute Acetaminophen Overdose During Pregnancy,&quot; <i>Obstet Gynecol</i>, 1989, 74(2):247-53.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/2748061/pubmed\" target=\"_blank\" id=\"2748061\">2748061</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Sachs HC, Committee On Drugs. The transfer of drugs and therapeutics into human breast milk: an update on selected topics. <i>Pediatrics</i>. 2013;132(3):e796-809.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/23979084/pubmed\" target=\"_blank\" id=\"23979084\">23979084</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med</i>. 2009;10(2):256-259.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/19188870/pubmed\" target=\"_blank\" id=\"19188870\">19188870</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Shelley WB, Talanin N, Shelley ED. Polysorbate 80 hypersensitivity. <i>Lancet</i>. 1995;345(8960):1312-1313.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/7746084 /pubmed\" target=\"_blank\" id=\"7746084 \">7746084 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Suhag A, Wood DC, Bisulli G, et al, &quot;Abstracts of the 18th World Congress on Ultrasound in Obstetrics and Gynecology. August 24-28, 2008. Chicago, Illinois, USA,&quot; <i>Ultrasound Obstet Gynecol</i>, 2008, 32(3):243-466.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/18696803/pubmed\" target=\"_blank\" id=\"18696803\">18696803</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Sullivan JE, Farrar HC. Fever and antipyretic use in children. <i>Pediatrics</i>. 2011;127(3):580-587.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/21357332/pubmed\" target=\"_blank\" id=\"21357332\">21357332</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Tylenol arthritis pain extended release caplets (acetaminophen) [prescribing information]. Fort Washington, PA: McNeil-PPC, Inc; 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Tylenol extra strength caplets (acetaminophen) [prescribing information]. Fort Washington, PA: McNeil-PPC, Inc; 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      Tylenol for Healthcare Professionals. Fort Washington, PA: McNeil-PPC, Inc; 2014. Available at http://www.tylenolprofessional.com/pediatrics.html</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Tylenol 8 HR extended release caplets (acetaminophen) [prescribing information]. Fort Washington, PA: McNeil-PPC, Inc; 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Tylenol regular strength tablets (acetaminophen) [prescribing information]. Fort Washington, PA: McNeil-PPC, Inc; 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    van den Anker JN, Tibboel D. Pain relief in neonates: when to use intravenous paracetamol. <i>Arch Dis Child</i>. 2011;96(6):573-574.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/21441241/pubmed\" target=\"_blank\" id=\"21441241\">21441241</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    van Lingen RA, Deinum HT, Quak CM, et al. Multiple-dose pharmacokinetics of rectally administered acetaminophen in term infants. <i>Clin Pharmacol Ther</i>. 1999;66(5):509-515.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/10579478/pubmed\" target=\"_blank\" id=\"10579478\">10579478</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Vernon S, Bacon C, Weightman D. Rectal paracetamol in small children with fever. <i>Arch Dis Child</i>. 1979;54(6):469-470.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/475432 /pubmed\" target=\"_blank\" id=\"475432 \">475432 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Viitanen H, Tuominen N, V&auml;&auml;r&auml;niemi H, Nikanne E, Annila P. Analgesic efficacy of rectal acetaminophen and ibuprofen alone or in combination for paediatric day-case adenoidectomy. <i>Br J Anaesth</i>. 2003;91(3):363-367.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/12925475 /pubmed\" target=\"_blank\" id=\"12925475 \">12925475 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Wang PH, Yang MJ, Lee WL, et al, &quot;Acetaminophen Poisoning in Late Pregnancy. A Case Report,&quot; <i>J Reprod Med</i>, 1997, 42(6):367-71.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/9219126/pubmed\" target=\"_blank\" id=\"9219126\">9219126</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Wilson-Smith EM, Morton NS. Survey of I.V. paracetamol (acetaminophen) use in neonates and infants under 1 year of age by UK anesthetists. <i>Paediatr Anaesth</i>. 2009;19(4):329-337.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/19335345/pubmed\" target=\"_blank\" id=\"19335345\">19335345</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Wood D, Shah S, Broth RE, et al, &quot;Abstracts of the 15th World Congress on Ultrasound in Obstetrics and Gynecology, 25-29 September 2005, Vancouver, Canada,&quot; <i>Ultrasound Obstet Gynecol</i>, 2005, 26(4):309-471.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/16152007/pubmed\" target=\"_blank\" id=\"16152007\">16152007</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    World Health Organization (WHO). Breastfeeding and maternal medication, recommendations for drugs in the eleventh WHO model list of essential drugs. 2002. Available at http://www.who.int/maternal_child_adolescent/documents/55732/en/</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Zar T, Graeber C, Perazella MA. Recognition, treatment, and prevention of propylene glycol toxicity. <i>Semin Dial</i>. 2007;20(3):217-219.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-pediatric-drug-information/abstract-text/17555487 /pubmed\" target=\"_blank\" id=\"17555487 \">17555487 </a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 13028 Version 180.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"ALERT: US Boxed Warning\" href=\"#F22782418\" class=\"outlineLink\">ALERT: US Boxed Warning</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F129318\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F129319\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Therapeutic Category\" href=\"#F1050747\" class=\"outlineLink\">Therapeutic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Neonatal\" href=\"#F11426603\" class=\"outlineLink\">Dosing: Neonatal</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Usual\" href=\"#F1050742\" class=\"outlineLink\">Dosing: Usual</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F129293\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Availability (US)\" href=\"#F129278\" class=\"outlineLink\">Generic Availability (US)</a></li><li class=\"plainItem\"><a sectionName=\"Product Availability\" href=\"#F49212230\" class=\"outlineLink\">Product Availability</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F1050752\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Storage/Stability\" href=\"#F129313\" class=\"outlineLink\">Storage/Stability</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F1050751\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F129376\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F129374\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F129300\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F129282\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Warnings: Additional Pediatric Considerations\" href=\"#F26522735\" class=\"outlineLink\">Warnings: Additional Pediatric Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F129365\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F129287\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Food Interactions\" href=\"#F129314\" class=\"outlineLink\">Food Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F5630924\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F129281\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics (Adult data unless noted)\" href=\"#F129299\" class=\"outlineLink\">Pharmacodynamics/Kinetics (Adult data unless noted)</a></li><li class=\"plainItem\"><a sectionName=\"Additional Information\" href=\"#F1050756\" class=\"outlineLink\">Additional Information</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F129302\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F129304\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_PED/13028|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">Acetaminophen (paracetamol): Drug information</a></li><li><a href=\"topic.htm?path=acetaminophen-paracetamol-patient-drug-information\" class=\"drug drug_patient\">Acetaminophen (paracetamol): Patient drug information</a></li></ul></div></div>","javascript":null}